Cargando…
SMYD3 promotes the epithelial–mesenchymal transition in breast cancer
SMYD3 is a methylase previously linked to cancer cell invasion and migration. Here we show that SMYD3 favors TGFβ-induced epithelial–mesenchymal transition (EMT) in mammary epithelial cells, promoting mesenchymal and EMT transcription factors expression. SMYD3 directly interacts with SMAD3 but it is...
Autores principales: | Fenizia, Claudio, Bottino, Cinzia, Corbetta, Silvia, Fittipaldi, Raffaella, Floris, Pamela, Gaudenzi, Germano, Carra, Silvia, Cotelli, Franco, Vitale, Giovanni, Caretti, Giuseppina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379668/ https://www.ncbi.nlm.nih.gov/pubmed/30544196 http://dx.doi.org/10.1093/nar/gky1221 |
Ejemplares similares
-
The Lysine Methylase SMYD3 Modulates Mesendodermal Commitment during Development
por: Fittipaldi, Raffaella, et al.
Publicado: (2021) -
SMYD1, the myogenic activator, is a direct target of serum response factor and myogenin
por: Li, Dali, et al.
Publicado: (2009) -
The interaction of lncRNA EZR-AS1 with SMYD3 maintains overexpression of EZR in ESCC cells
por: Zhang, Xiao-Dan, et al.
Publicado: (2018) -
c-MYC empowers transcription and productive splicing of the oncogenic splicing factor Sam68 in cancer
por: Caggiano, Cinzia, et al.
Publicado: (2019) -
The androgen receptor couples promoter recruitment of RNA processing factors to regulation of alternative polyadenylation at the 3' end of transcripts
por: Caggiano, Cinzia, et al.
Publicado: (2022)